Skip to content
Politically.com Search all
Menu

2026 · 3rd Quarter (July 1 - Sep 30)

THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES

Filed by MAGILL ASSOCIATES, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-11-04 06:26:19 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 1, 2026
Income
Not reported
Expenses
Not reported
Filing UUID
f0ac4e99-19df-465b-9877-11be86328346
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

FY 2027 appropriations for the development of a synthetic vaccine

MED · Medical/Disease Research/Clinical Labs

FY 2027 appropriations for the development of a synthetic vaccine

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.